Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

NCT05123001 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05123001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05123001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
Lead sponsor
Stanford University
Phase
Observational
Overall status
Completed
Start date
July 15, 2021
Completion date
July 7, 2022
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma, leukemia, multiple myeloma, non hodgkin lymphoma